Sequre Arcsp. z o.o.

Other computer programming activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2025-05-12
Share capital
5,000.00 PLN
Registered address
ul. Marii Konopnickiej 4/2, 05-220 Zielonka, Poland
Electronic delivery address
AE:PL-68225-94607-IBJWD-23

Financials

Filing timeliness

1 of 1 financial statements was filed late (for 2025, 77 days late).

  • 202530/09/2026
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Other computer programming activities1,374 / 1,588
Top 87%
Sector · Financial and insurance activities2,397 / 2,774
Top 86%
City · Zielonka114 / 122
Top 93%
Voivodeship · Mazowieckie68,805 / 77,210
Top 89%
Country · Poland269,839 / 298,279
Top 90%

Results vs industry

Revenue
This companyUSD 4.05kMedianUSD 130.66kAverageUSD 3.82m
Net profit
This companyUSD 2.57kMedianUSD 3.70kAverageUSD 320.51k
Operating costs
This companyUSD 1.18kMedianUSD 118.05kAverageUSD 3.38m
Assets
This companyUSD 3.85kMedianUSD 83.53kAverageUSD 3.37m

Authorized Representatives

Karolina Maria Gosztyła-Korabage 32 – President of the Management Board
Szymon Piotr Korabage 33 – Attorney-in-fact

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
50$675.3150%
50$675.3150%

The articles of association require board approval for share transfers.

Beneficial owners

Person

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
Addeptosp. z o.o.
Algomine Groupsp. z o.o.
Bakksp. z o.o.
Syndatissp. z o.o.
Appotypesp. z o.o.
Apperise Groupsp. z o.o.
AgenticP.S.A.
Admedisp. z o.o.
Apperturesp. z o.o.
044 Soulsp. z o.o.

FAQ

Last updated: 2026-09-30